The Good Manufacturing Practice (GMP) Unit is a flexible space to make cell and gene therapies for clinical trials.
The growing field of medicine, termed Advanced Therapy Medicinal Products (ATMPs), heralds a new era in patient care and treatment. These ATMPs are used to treat major indications that are currently unmet. However, as with all medicines, their safety and efficacy must be determined through clinical trials.
The Unit is currently manufacturing patient-specific ATMPs for clinical trials in head and neck cancer and recipients of liver or kidney transplants.
The GMP Unit is strategically placed within Guy’s Hospital to undertake the manufacturing requirements of ATMP clinical trials in collaboration with King’s College London and Commercial Companies. Our expertise is in closed-system cell cultures and purification.
The GMP unit consists of three equipped clean-rooms flexibly designed to accommodate multiple production processes. The scale is small, perfect for early-phase trials.
The BRC GMP unit is operational for 48 weeks per year, between 08:00 and 20:00 hours each day. We run a hotel-style booking system, with three four-hour sessions daily per room.
Chris Fisher, GMP Production Manager
Tel: +44 (0)207 188 7188 ext. 52362
Dr Drew Hope, GMP Quality Manager
Tel: +44 (0)207 188 7188 ext. 52703
NIHR GSTFT/KCL Biomedical Research Centre (BRC) GMP Unit
Clinical Research Facility
15th Floor, Tower Wing
Great Maze Pond
ATMP Manufacturing Community
Cell Therapy Catapult
eXmoor Pharma Concepts Ltd
Human Tissue Authority (HTA)
London Regenerative Medicine Network
Medicines and Healthcare products Regulatory Agency (MHRA)